The North America Dialyzer Market would witness market growth of 5.58% CAGR during the forecast period (2019-2025).
North America was dominant across the regional market, accounting for the largest market share, and is expected to maintain this trend throughout the forecast period. This trend can be attributed to the substantial surge in the incidence of end-stage renal disease (ESRD), hypertension, diabetes, and others in this region.
Technological advancements in nanotechnology have enabled technological developments in dialyzer design and manufacturing to enable for both more effective small solvent clearances and a wider range of solvent clearance. This has prompted new models that enhance blood flow and dialysate pathways within the dialyzer to maximize the concentration gradient and enhance diffusive clearances. About raising interest in hemodiafiltration, dialyzers specifically intended for convective clearance are now accessible These have also combined high hydraulic permeability with dialyzer fiber sizes to balance fiber diameter, length, and hydraulic pressure to enable high volume hemodiafiltration while preventing enhanced filtration fraction.
Based on Type, the market is segmented into High-Flux Dialyzer and Low-Flux Dialyzer. Based on End User, the market is segmented into In-Center Dialysis and Home Dialysis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., CVS Health Corporation, Fresenius Medical Care AG & Co. KGaA, DaVita, Inc., Asahi Kasei Corporation, Cardinal Health, Inc., Cantel Medical Corporation, Nipro Corporation, Allmed Medical Care Holdings Limited and Terumo Corporation.
Market Segmentation:
By Type
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
